Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Mindera Raises Over $12 Million Series A-2 Financing

Mindera Corporation announced a $12.6 Million Series A-2 capital raise. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development. The funding will be used to commercialize Mind.Px, a groundbreaking tool to prospectively predict patient response to expensive psoriasis biologics, as well as continue development of the Mindera Dermal Intelligence Platform.

Recommended AI News: Mosyle Sets the First Standard for Apple Device Security in K-12 Schools

Related Posts
1 of 16,683

The Mindera platform uses a simple patch that extracts biomarkers from the skin in minutes, allowing for rapid and painless extraction of RNA. Subsequent Next-Generation Sequencing of the extracted RNA allows Mindera scientists to take a genetic and transcriptomic snapshot of the skin at the exact moment of the test. In the case of Mind.Px, this rich patient-specific data is then analyzed by proprietary machine learning algorithms to predict the appropriate psoriasis biologic drug for a patient prior to therapeutic selection and treatment.

Mind.Px is a first-of-its-kind precision medicine dermatology solution that aligns patient, physician, and payer interests by predicting effective biologics for individuals, avoiding trial-and-error prescription behavior and wasted payer spending. 

Recommended AI News: Mundrisoft partners with a leading US-Based EdTech Company to Accelerate Learning Delivery

Comments are closed.